deucravacitinib,Apremilast
bms,amgen
['psoriasis', '$bmy']
u.s. food and drug administration approves sotyktu , oral treatment for adults with moderate-to-severe plaque psoriasis $bmy 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice